PTPRH is a member of the protein tyrosine phosphatase (PTP) family, which plays a role in removing phosphate groups from tyrosine residues of proteins. Activators of PTPRH would therefore be molecules that enhance the phosphatase activity of PTPRH. This could involve stabilizing the enzyme in an active conformation, promoting binding to its substrates, or altering its interaction with regulatory proteins. The chemical structures of PTPRH Activators could vary widely, ranging from small organic molecules to larger biomolecules, each designed to engage with specific structural features of PTPRH to potentiate its enzymatic activity.
The development of PTPRH Activators would involve a multistep research process beginning with a thorough understanding of the PTPRH enzyme's structure and function. Techniques such as X-ray crystallography or cryo-electron microscopy might be employed to determine the three-dimensional structure of PTPRH, particularly the configuration of its catalytic site and any regulatory domains. This structural knowledge would guide the design of molecules that could bind to and increase the activity of PTPRH. Computational chemistry and molecular modeling would play an integral role in predicting how potential activators could interact with the enzyme, and these predictions would be tested using in vitro assays to measure enzymatic activity in the presence of these compounds. High-throughput screening methods could initially identify lead compounds that show potential as PTPRH Activators, which would then undergo a process of optimization. Medicinal chemists would iteratively modify these lead compounds to improve their potency, specificity, and stability as activators of PTPRH. Such an optimization process would employ structure-activity relationship (SAR) studies, which correlate changes in molecular structure with changes in biological activity. Through these studies, a collection of specialized compounds could be created that are capable of selectively modulating the activity of PTPRH, contributing to the basic understanding of its function and the intricate network of protein regulation in which it operates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to modulate several signaling pathways, which could potentially influence the expression of genes, including PTPRH. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As an isoflavone, genistein may act as a tyrosine kinase inhibitor, which could affect tyrosine phosphorylation status and alter gene expression profiles, including PTPRH. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
This compound has multiple cellular targets and can affect transcription factors, potentially leading to altered gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can modulate signal transduction pathways that affect gene expression, potentially influencing PTPRH expression levels. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
As an isothiocyanate, sulforaphane may influence gene expression through the modulation of transcription factor activity. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Known as a flavonoid, quercetin may affect gene expression by modulating kinase signaling pathways. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Arsenite can affect signal transduction and transcriptional control, which could potentially lead to changes in gene expression. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $56.00 $183.00 $352.00 | 1 | |
Cadmium exposure can affect cellular signaling pathways and may result in altered gene expression, including that of receptor-type PTPs. | ||||||
Lead(II) Acetate | 301-04-2 | sc-507473 | 5 g | $85.00 | ||
Lead can interfere with various signaling pathways and transcriptional processes, potentially influencing the expression of certain genes. | ||||||